Picton Mahoney Asset Management’s MedTech Acquisition Corporation Unit MTACU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-225,000
Closed -$2.36M 415
2020
Q4
$2.36M Buy
+225,000
New +$2.35M 0.11% 212

Other funds holding MTACU

Picton Mahoney Asset Management's MTACU Position: Q1 2021 in Review

Picton Mahoney Asset Management sold out of MedTech Acquisition Corporation Unit (MTACU) in Q1 2021, closing a stake of 225,000 shares — an estimated $2.36M sold.

Picton Mahoney Asset Management first reported a position in MTACU in Q4 2020 and held it in 1 quarter. The position peaked at $2.36M in Q4 2020. 31 funds tracked by Wall St. Rank hold MTACU as of Q1 2021.

  • Picton Mahoney Asset Management reported no remaining MedTech Acquisition Corporation Unit position as of Q1 2021 after selling out during the quarter.
  • Picton Mahoney Asset Management sold 225,000 MedTech Acquisition Corporation Unit shares in Q1 2021, an estimated $2.36M.
  • Picton Mahoney Asset Management first reported a position in MedTech Acquisition Corporation Unit in Q4 2020 and held it in 1 quarter.
  • Picton Mahoney Asset Management's MedTech Acquisition Corporation Unit position peaked at $2.36M in Q4 2020.
  • 31 funds tracked by Wall St. Rank held MedTech Acquisition Corporation Unit as of Q1 2021.

Based on Picton Mahoney Asset Management's 13F filing for Q1 2021, filed 4 May 2021.